By Debdeep Gupta | March, 18 2026
Mankind Pharma buys rights to Rivotril, deepening central nervous system therapy push
mankind pharma has acquired the indian rights to rivotril, the long?established brand from swiss giant roche, to scale its presence in chronic and central nervous system (cns) therapies, the new delhi-based company said on march 18, without sharing the financial details for the deal.the deal grants mankind exclusive rights to manufacture, market and distribute the drug in india, the company said.at 11.04 am, mankind stock was trading at r







